Read + Share
Amedeo Smart
Independent Medical Education
Yoshihama Y, LaBella KA, Kim E, Bertolet L, et al. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase. Proc Natl Acad Sci U S A 2021;118.PMID: 34475205
Email
LinkedIn
Facebook
Twitter
Privacy Policy